Toll-like receptor 4 deficiency causes pulmonary emphysema

Journal of Clinical Investigation

Volumn 116, Issue 11, 2006, Pages 3050-3059

  Zhang, Xuchen ^a   Shan, Peiying ^a   Jiang, Ge ^a   Cohn, Lauren ^a   Lee, Patty J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; ENDOTHELIUM CELL; LUNG ALVEOLUS CELL; LUNG EMPHYSEMA; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANIMALS; ANTIOXIDANTS; CELLS, CULTURED; ELASTIN; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NADPH OXIDASE; OXIDANTS; PANCREATIC ELASTASE; PULMONARY EMPHYSEMA; TOLL-LIKE RECEPTOR 4;

EID: 33750580556     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28139     Document Type: Article

References (78)

1. Zhang, X., et al. 2005. Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury. J. Immunol. 175:4834-4838.
2. Qureshi, S.T., et al. 2006. Inducible activation of TLR4 confers resistance to hyperoxia-induced pulmonary apoptosis. J. Immunol. 176:4950-4958.
3. Jiang, D., et al. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11:1173-1179.
4. MacNee, W. 2005. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2:50-60.
5. Rennard, S.I., and Vestbo, J. 2006. COPD: the dangerous underestimate of 15%. Lancet. 367:1216-1219.
6. Devereux, G. 2006. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ. 332:1142-1144.
7. Martorana, P.A., et al. 1993. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency. Lab. Invest. 68:233-241.
8. Hautamaki, R.D., Kobayashi, D.K., Senior, R.M., and Shapiro, S.D. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science. 277:2002-2004.
9. Kuro-o, M., et al. 1997. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 390:45-51.
10. Wert, S.E., et al. 2000. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl. Acad. Sci. U. S. A. 97:5972-5977.
11. Smith, C.A., and Harrison, D.J. 1997. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 350:630-633.
12. Rangasamy, T., et al. 2004. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114:1248-1259. doi:10.1172/JCI200421146.
13. Kaisho, T., and Akira, S. 2006. Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 117:979-987; quiz 988.
14. Lappalainen, U., Whitsett, J.A., Wert, S.E., Tichelaar, J.W., and Bry, K. 2005. Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am. J. Respir. Cell Mol. Biol. 32:311-318.
15. Lee, C.G., et al. 2004. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat. Med. 10:1095-1103.
16. Zheng, T., et al. 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase-and cathepsin-dependent emphysema. J. Clin. Invest. 106:1081-1093.
17. Zheng, T., et al. 2005. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J. Immunol. 174:8106-8115.
18. Barnes, P.J., Shapiro, S.D., and Pauwels, R.A. 2003. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur. Respir. J. 22:672-688.
19. Stoller, J.K., and Aboussouan, L.S. 2005. Alpha1-antitrypsin deficiency. Lancet. 365:2225-2236.
20. Shapiro, S.D. 2002. Proteinases in chronic obstructive pulmonary disease. Biochem. Soc. Trans. 30:98-102.
21. Elkington, P.T., and Friedland, J.S. 2006. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 61:259-266.
22. Finlay, G.A., et al. 1997. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am. J. Respir. Crit. Care Med. 156:240-247.
23. Demedts, I.K., et al. 2006. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax. 61:196-201.
24. Taggart, C., et al. 2000. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275:27258-27265.
25. Zhang, X., Shan, P., Sasidhar, M., Choi, A.M.K., and Lee, P.J. 2003. Reactive oxygen species and ERK-mitogen activated protein kinase mediate hyperoxia-induced apoptosis in lung epithelium. Am. J. Resp. Cell Mol. Biol. 28:305-315.
26. Becker, L.B., vanden Hoek, T.L., Shao, Z.H., Li, C.Q., and Schumacker, P.T. 1999. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am. J. Physiol. 277:H2240-H2246.
27. Li, J.M., Mullen, A.M., and Shah, A.M. 2001. Phenotypic properties and characteristics of superoxide production by mouse coronary microvascular endothelial cells. J. Mol. Cell. Cardiol. 33:1119-1131.
28. Pratico, D., et al. 1998. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am. J. Respir. Crit. Care Med. 158:1709-1714.
29. Kasahara, Y., et al. 2000. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest. 106:1311-1319.
30. Yokohori, N., Aoshiba, K., and Nagai, A. 2004. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest. 125:626-632.
31. Spurzem, J.R., and Rennard, S.I. 2005. Pathogenesis of COPD. Semin. Respir. Crit. Care Med. 26:142-153.
32. Tuder, R.M., et al. 2003. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am. J. Respir. Cell Mol. Biol. 29:88-97.
33. Crapo, J.D., Barry, B.E., Foscue, H.A., and Shelburne, J. 1980. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122:123-143.
34. Kasahara, Y., et al. 2001. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am. J. Respir. Crit. Care Med. 163:737-744.
35. Lu, Q., Harrington, E.O., and Rounds, S. 2005. Apoptosis and lung injury. Keio J. Med. 54:184-189.
36. Toborek, M., and Hennig, B. 1993. Vitamin E attenuates induction of elastase-like activity by tumor necrosis factor-alpha, cholestan-3 beta,5 alpha,6 beta-triol and linoleic acid in cultured endothelial cells. Clin. Chim. Acta. 215:201-211.
37. West, D.C., and Kumar, S. 1986. Elastase activity in capillary and aortic endothelial cells. Anticancer Res. 6:1069-1072.
38. Menashi, S., Hornebeck, W., Robert, L., and Legrand, Y. 1989. Elastase-like activity in cultured aortic endothelial cells. Thromb. Res. 53:11-18.
39. Laug, W.E., Weinblatt, M.E., and Jones, P.A. 1985. Endothelial cells degrade extracellular matrix proteins produced in vitro. Thromb. Haemost. 54:498-502.
40. Faure, E., et al. 2000. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275:11058-11063.
41. Hougee, S., et al. 2006. Oral administration of the NADPH-oxidase inhibitor apocynin partially restores diminished cartilage proteoglycan synthesis and reduces inflammation in mice. Eur. J. Pharmacol. 531:264-269.
42. Furukawa, S., et al. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114:1752-1761. doi:10.1172/JCI200421625.
43. Boldogh, I., et al. 2005. ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J. Clin. Invest. 115:2169-2179. doi:10.1172/JCI24422.
44. Geiszt, M., and Leto, T.L. 2004. The Nox family of NAD(P)H oxidases: host defense and beyond. J. Biol. Chem. 279:51715-51718.
45. Lambeth, J.D. 2004. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4:181-189.
46. Owen, C.A. 2005. Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2:373-385.
47. Iizuka, T., et al. 2005. Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells. 10:1113-1125.
48. Ishii, Y., et al. 2005. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inf lammation and emphysema. J. Immunol. 175:6968-6975.
49. Babior, B.M., Lambeth, J.D., and Nauseef, W. 2002. The neutrophil NADPH oxidase. Arch. Biochem. Biophys. 397:342-344.
50. Ueyama, T., Geiszt, M., and Leto, T.L. 2006. Involvement of Rac1 in activation of multicomponent Nox1- and Nox3-based NADPH oxidases. Mol. Cell. Biol. 26:2160-2174.
51. Griendling, K.K., Sorescu, D., and Ushio-Fukai, M. 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86:494-501.
52. Zalba, G., et al. 2001. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension. 38:1395-1399.
53. Yang, S., Madyastha, P., Bingel, S., Ries, W., and Key, L. 2001. A new superoxide-generating oxidase in murine osteoclasts. J. Biol. Chem. 276:5452-5458.
54. Jones, S.A., Hancock, J.T., Jones, O.T., Neubauer, A., and Topley, N. 1995. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J. Am. Soc. Nephrol. 5:1483-1491.
55. Shiose, A., et al. 2001. A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276:1417-1423.
56. Radeke, H.H., et al. 1991. Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J. Biol. Chem. 266:21025-21029.
57. Cheng, G., Cao, Z., Xu, X., van Meir, E.G., and Lambeth, J.D. 2001. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene. 269:131-140.
58. Paffenholz, R., et al. 2004. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev. 18:486-491.
59. Banfi, B., et al. 2004. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J. Biol. Chem. 279:46065-46072.
60. MacNee, W. 2005. Pathogenesis of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2:258-266; discussion 290-291.
61. Shapiro, S.D., et al. 2003. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am. J. Pathol. 163:2329-2335.
62. Platt, M.O., Ankeny, R.F., and Jo, H. 2006. Laminar shear stress inhibits cathepsin L activity in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26:1784-1790.
63. Mueller-Anneling, L., Avol, E., Peters, J.M., and Thorne, P.S. 2004. Ambient endotoxin concentrations in PM10 from Southern California. Environ. Health Perspect. 112:583-588.
64. Klut, M.E., et al. 1996. Neutrophil activation and lung injury associated with chronic endotoxemia in rabbits. Exp. Lung Res. 22:449-465.
65. Stolk, J., et al. 1992. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. J. Pathol. 167:349-356.
66. Eisenbarth, S.C., et al. 2002. Lipopolysaccharideenhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196:1645-1651.
67. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., and Medzhitov, R. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 118:229-241.
68. Adachi, O., et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:143-150.
69. Hoshino, K., et al. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
70. D'Agostini, F., Balansky, R.M., Camoirano, A., and De Flora, S. 2005. Modulation of light-induced skin tumors by N-acetylcysteine and/or ascorbic acid in hairless mice. Carcinogenesis. 26:657-664.
71. Hart, B.A., Elferink, J.G., and Nibbering, P.H. 1992. Effect of apocynin on the induction of ulcerative lesions in rat skin injected with tubercle bacteria. Int. J. Immunopharmacol. 14:953-961.
72. Cohn, L., Herrick, C., Niu, N., Homer, R., and Bottomly, K. 2001. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J. Immunol. 166:2760-2767.
73. Lee, P.J., et al. 2006. ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J. Clin. Invest. 116:163-173. doi:10.1172/JCI25711.
74. Kuhlencordt, P.J., et al. 2004. Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells. Am. J. Physiol. Cell Physiol. 286:C1195-C1202.
75. Zhang, X., et al. 2004. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J. Biol. Chem. 279:10677-10684.
76. Rust, L., Messing, C.R., and Iglewski, B.H. 1994. Elastase assays. Methods Enzymol. 235:554-562.
77. Klumpp, T., and Bieth, J.G. 1979. Automated measurement of the elastase-inhibitory capacity of plasma with a centrifugal analyzer. Clin. Chem. 25:969-972.
78. Cavarra, E., et al. 2001. Effects of cigarette smoke in mice with different levels of alpha(1)-proteinase inhibitor and sensitivity to oxidants. Am. J. Respir. Crit. Care Med. 164:886-890.